Hans von Celsing

Hans von Celsing

76 anni
Health Technology
Finance
Health Services

Profilo

Hans Henrik von Celsing is the founder of NeuroVentures Capital LLC.
Current positions include Chairman at ADAM SA, Chairman at Partner Fondkommission AB since 2013, Chairman at Oscar Properties Holding AB since 2024, and Senior Independent Non-Executive Director at Advanced Oncotherapy Plc since 2017.
Former roles include Chief Executive Officer at Plasma Surgical Ltd., Chairman at Peptonic Medical AB from 2016 to 2022, Executive Chairman at Clinical Laserthermia Systems AB from 2015 to 2024, Director at Mevion Medical Systems, Inc., Trondheim Estate AS, and Mirada Medical Ltd., Executive Director at Gelmetix Ltd., Executive Vice President at Elekta AB from 1985 to 1999, Executive Vice President at Elekta Holdings US, Inc., and Principal at Bioxydyn Ltd. Education includes undergraduate and MBAistration degrees from Harvard Business School.

Posizioni attive di Hans von Celsing

SocietàPosizioneInizio
ADVANCED ONCOTHERAPY PLC Direttore/Membro del Consiglio 26/01/2017
OSCAR PROPERTIES HOLDING AB Presidente 17/06/2024
Fondatore -
Presidente 01/10/2013
Presidente -

Precedenti posizioni note di Hans von Celsing

SocietàPosizioneFine
CLINICAL LASERTHERMIA SYSTEMS AB Presidente 01/01/2024
Amministratore Delegato 01/01/2007
ELEKTA AB Corporate Officer/Principal 01/01/1999
Corporate Officer/Principal -
░░░░░░░░ ░░░░░░░ ░░ ░░░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Hans von Celsing

Formazione di Hans von Celsing

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

43

Relazioni di 1° grado

16

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private16

Health Technology

Health Technology

Health Technology

Finance

Electronic Technology

Health Services

Health Technology

Finance

Technology Services

Health Services

Health Technology

Health Technology

Health Technology

Consumer Services

Finance

Commercial Services

  1. Mercati
  2. Insiders
  3. Hans von Celsing
- 40% : I migliori strumenti riservati agli abbonati per individuare le opportunità di investimento di domani.
g
:
:
ENTRA ORA